Table 5.
Patients with reported adverse events or serious adverse events
| Biomarker-guided recommendation on antibiotics group (n=103) | Routine use of antibiotics group (n=106) | ||
|---|---|---|---|
| Adverse event or serious adverse event reported | 43 (42%) | 37 (35%) | |
| Adverse event recorded | 39 (91%) | 35 (95%) | |
| Serious adverse event recorded | 4 (9%) | 2 (5%) | |
Data are number of patients (%); multiple events were reported in some patients.